Shin M, Kurita H, Sasaki T, Kawamoto S, Tago M, Kawahara N, Morita A, Ueki K, Kirino T
Department of Neurosurgery, The University of Tokyo Hospital, Japan.
J Neurosurg. 2001 Sep;95(3):435-9. doi: 10.3171/jns.2001.95.3.0435.
The long-term outcome of stereotactic radiosurgery for cavernous sinus (CS) meningiomas is not fully understood. The authors retrospectively reviewed their experience with 40 CS meningiomas treated with gamma knife radiosurgery.
Follow-up periods for the 40 patients ranged from 12 to 123 months (median 42 months), and the overall tumor control rates were 86.4% at 3 years and 82.3% at 10 years. Factors associated with tumor recurrence in univariate analysis were histological malignancy (p < 0.0001), partial treatment (p < 0.0001), suprasellar tumor extension (p = 0.0201), or extension in more than three directions outside the CS (p = 0.0345). When the tumor was completely covered with a dose to the margin that was higher than 14 Gy (Group A, 22 patients), no patient showed recurrence within the median follow-up period of 37 months. On the other hand, when a part of the tumor was treated with 10 to 12 Gy (Group B, 15 patients) or did not receive radiation therapy (Group C, three patients), the recurrence rates were 20% and 100%, respectively. Neurological deterioration was seen in nine patients, but all symptoms were transient or very mild.
The data indicate that stereotactic radiosurgery can control tumor growth if the whole mass can be irradiated by dosages of more than 14 Gy. When optimal radiosurgical planning is not feasible because of a tumor's large size, irregular shape, or proximity to visual pathways, use of limited surgical resection before radiosurgery is the best option and should provide sufficient long-term tumor control with minimal complications.
海绵窦(CS)脑膜瘤立体定向放射外科治疗的长期疗效尚未完全明确。作者回顾性分析了40例接受伽玛刀放射外科治疗的CS脑膜瘤患者的治疗经验。
40例患者的随访时间为12至123个月(中位时间42个月),3年时总体肿瘤控制率为86.4%,10年时为82.3%。单因素分析中与肿瘤复发相关的因素包括组织学恶性程度(p < 0.0001)、部分治疗(p < 0.0001)、鞍上肿瘤扩展(p = 0.0201)或CS外三个以上方向的扩展(p = 0.0345)。当肿瘤边缘剂量高于14 Gy完全覆盖时(A组,22例患者),在37个月的中位随访期内无患者出现复发。另一方面,当肿瘤部分接受10至12 Gy治疗时(B组,15例患者)或未接受放射治疗时(C组,3例患者),复发率分别为20%和100%。9例患者出现神经功能恶化,但所有症状均为短暂或非常轻微。
数据表明,如果能以超过14 Gy的剂量照射整个肿瘤,立体定向放射外科可以控制肿瘤生长。当由于肿瘤体积大、形状不规则或靠近视觉通路而无法进行最佳放射外科规划时,在放射外科治疗前进行有限的手术切除是最佳选择,应能以最小的并发症提供足够的长期肿瘤控制。